Buying guide
How to choose and verify a research peptide
What to check before ordering: assay method, batch documentation, storage requirements and intended research use.
Understanding incretin pathway research
The incretin effect describes the observation that oral glucose provokes a much larger insulin response than the same glucose delivered intravenously. The difference is produced by gut-derived hormones — principally GLP-1 and GIP — released in response to nutrients in the intestinal lumen. Research analogues in this category are tools for dissecting that system receptor by receptor.
GLP-1 receptor agonists engage a class B G-protein-coupled receptor, driving cAMP accumulation and downstream insulinotropic signalling in beta-cell models, with additional effects observed in gastric emptying and central appetite circuits. GIP receptor engagement produces a different signalling and internalisation profile, which is why dual agonists are not simply stronger single agonists. Adding glucagon receptor activity introduces an energy-expenditure arm that pulls in the opposite direction on glucose while increasing metabolic rate in the models used to study it.
Comparative work is the norm here: single, dual and triple agonists run in parallel under identical conditions, because the interesting variable is the relative contribution of each receptor rather than the absolute response of any one.
Practical notes for this category
These analogues are engineered for extended half-life, often through fatty acid side chains that promote albumin binding. In cell culture that binding matters: serum albumin in the medium sequesters a fraction of the compound, so nominal and free concentrations diverge. Protocols comparing analogues with different albumin affinities should account for it rather than assuming nominal concentration equals exposure.
Reconstituted stocks should be aliquoted before freezing if they will outlast the twenty-eight day refrigerated window, since repeated freeze-thaw cycling degrades these longer sequences faster than the shorter peptides elsewhere in the catalogue.
How the catalogue is organised
Compounds are grouped by the biological pathway they are used to study rather than by chemical class, because that is how research protocols are actually built. A team modelling tissue repair needs BPC-157, TB-500 and GHK-Cu in the same place; a team working on incretin signalling needs semaglutide, tirzepatide and retatrutide side by side with their purity figures visible for comparison. The category filters above reflect those working groupings.
GLP-1 and metabolic covers the incretin receptor agonists and analogues used in energy balance and insulin secretion research. Regeneration and repair holds the tissue signalling sequences. Growth factor collects the GH secretagogues and hGH fragments. Cellular and longevity covers mitochondrial, telomere and dermal matrix compounds. Neuroactive holds the CNS and cognition peptides. Gonadotropin covers the endocrine axis reference standards. Stacks are matched batch sets, and lab supplies are the consumables and diluents that every protocol needs alongside the compounds themselves.
Reading a product listing
Every listing shows four things that matter before price: the compound name, the vial size in milligrams or international units, the assayed purity percentage for the current lot, and the batch code. The purity figure is not a specification or a target — it is the result the HPLC run produced for the material you will receive, and it is reproduced on the certificate you can search in the library.
Vial size is stated as the mass of lyophilised peptide in the vial, not as a concentration, because concentration depends entirely on the volume of bacteriostatic water you choose to reconstitute with. A 5mg vial reconstituted with 2ml of diluent gives a 2.5mg/ml stock; the same vial with 5ml gives 1mg/ml. Choose the volume that puts your working concentration in a range your pipettes can measure accurately.
Batch codes follow a compound-month-run format, so BP-2408-D is the fourth production run of BPC-157 assayed in August 2024. Quoting that code in an enquiry lets us pull the exact analytical trace rather than the summary certificate.
Choosing between similar compounds
Several groups in the catalogue contain compounds that look interchangeable and are not. Among the incretins, semaglutide is a single GLP-1 receptor agonist, tirzepatide adds GIP receptor activity, and retatrutide adds glucagon receptor activity on top of both. Choosing between them is choosing how many receptor arms your model needs to isolate — running all three in parallel is the standard comparative design.
In the growth factor group, ipamorelin is a selective ghrelin receptor agonist and CJC-1295 without DAC is a GHRH analogue. They act on different receptors on the same cell population, which is why they appear together in so many protocols; AOD9604 is neither, being an hGH fragment studied for direct adipocyte effects rather than for a secretagogue response.
In the repair group, BPC-157 is associated with angiogenic signalling and TB-500 with actin-driven cell migration. The blend vial exists so that experiments needing both do not have to reconcile two separate batch histories and two reconstitution volumes.
Dispatch, packaging and what arrives
Orders placed before 3pm on a working day leave the London facility the same day on a free tracked next-day service within the UK. International orders go out within forty-eight hours on a tracked courier. Vials are sealed, cushioned and boxed with the batch documentation, and tracking is emailed as soon as the label is generated.
Every compound listed is supplied for in-vitro laboratory research by qualified personnel only. Nothing in this catalogue is a medicine and nothing is intended for human or veterinary use.